| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/11/2009 | US20090149397 Treatment of cancer with combinations of topoisomerase inhibitors and parp inhibitors |
| 06/11/2009 | US20090149396 Derivative of glucose and vitamin f, compositions comprising it, uses and preparation process |
| 06/11/2009 | US20090149395 Novel macrocyclic polyene lactams |
| 06/11/2009 | US20090149394 Use of effectors of glutaminyl and glutamate cyclases |
| 06/11/2009 | US20090149392 Abuse-resistant amphetamine prodrugs |
| 06/11/2009 | US20090149381 Methods of regulating angiogenesis through stabilization of PEDF |
| 06/11/2009 | US20090149380 Vasostatin as marrow protectant |
| 06/11/2009 | US20090149379 Novel use of cytokine inhibitors |
| 06/11/2009 | US20090149376 Pharmaceutical and Therapeutic Applications Relating to a Type 9 Adenylyl Cyclase Polymorphism in Asthma and Reversible Bronchial Obstruction |
| 06/11/2009 | US20090149375 Use of the mst protein for the treatment of a thromboembolic disorder |
| 06/11/2009 | US20090149373 Use of survivin to treat kidney failure |
| 06/11/2009 | US20090148945 Novel Biodegradable Elastomeric Scaffold for Tissue Engineering and Light Scattering Fingerprinting Methods for Testing the Same |
| 06/11/2009 | US20090148854 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 06/11/2009 | US20090148566 Carbohydrate And Electrolyte Replacement Composition |
| 06/11/2009 | US20090148546 Methods and compounds fo rthe treatment of obesity and obesity-related disorders |
| 06/11/2009 | US20090148545 Methods of use and nutritional compositions of touchi extract |
| 06/11/2009 | US20090148543 Method for protecting humans against superficial vasodilator flush syndrome, |
| 06/11/2009 | US20090148541 Compositions and methods for the treatment of seborrhea |
| 06/11/2009 | US20090148539 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090148537 Medical composition |
| 06/11/2009 | US20090148533 Ion binding compositions |
| 06/11/2009 | US20090148532 Preparation of controlled release skeletal muscle relaxant dosage forms |
| 06/11/2009 | US20090148531 Rate-controlled particles |
| 06/11/2009 | US20090148529 Hydrogel Suspension and Manufacturing Process Thereof |
| 06/11/2009 | US20090148526 Salts of potassium atp channel openers and uses thereof |
| 06/11/2009 | US20090148525 Pharmaceutical formulations of potassium atp channel openers and uses thereof |
| 06/11/2009 | US20090148524 Method of producing solid preparation disintegrating in the oral cavity |
| 06/11/2009 | US20090148519 Pulsed-release preparation having improved disintegration properties in vivo |
| 06/11/2009 | US20090148517 Melt-extrusion multiparticulates |
| 06/11/2009 | US20090148512 Novel uses of chloramphenicol and analogous thereof |
| 06/11/2009 | US20090148511 Composition and method for dermatological treatment |
| 06/11/2009 | US20090148509 Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles |
| 06/11/2009 | US20090148508 Methods of compositions for the treatment of ocular diseases |
| 06/11/2009 | US20090148504 Transdermal pharmaceutical preparation |
| 06/11/2009 | US20090148502 Compositions and methods for treating lacerations, abrasions, avulsions, burns, ulcers, and cases of excessive bleeding |
| 06/11/2009 | US20090148499 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 06/11/2009 | US20090148498 Controlled release implantable dispensing device and method |
| 06/11/2009 | US20090148497 Antibiotic Microspheres for Treatment and Prevention Of Osteomyelitis and Enhancement of Bone Regrowth |
| 06/11/2009 | US20090148496 Implants with membrane diffusion-controlled release of active ingredient |
| 06/11/2009 | US20090148494 Egfr inhibitors promote axon regeneration |
| 06/11/2009 | US20090148493 Methods and devices for enhanced biocompatibility |
| 06/11/2009 | US20090148482 Device, System, And Method Comprising Microencapsulated Proton Donor For Release Of Nitric Oxide From A Polymer |
| 06/11/2009 | US20090148478 Combinations of tumor-associated antigens in compositions for various types of cancers |
| 06/11/2009 | US20090148471 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 06/11/2009 | US20090148468 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 06/11/2009 | US20090148459 Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents |
| 06/11/2009 | US20090148454 Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148450 ATF4 As A Therapeutic Target In Alzheimers Disease And Other Neurological Disorders |
| 06/11/2009 | US20090148449 Antibodies against cd38 for treatment of multiple myeloma |
| 06/11/2009 | US20090148445 Methods of sensitizing cancer to therapy-induced cytotoxicity |
| 06/11/2009 | US20090148444 Pharmaceutical composition for treating immune diseases |
| 06/11/2009 | US20090148439 by use of a polypeptide (CD27L); in particular kidney cancer; monitoring the effectiveness of epithelial-derived cancer therapy |
| 06/11/2009 | US20090148432 applying an antiproliferative agent capable of removing sialic acid residues, such as trans-sialidase, neuraminidase with plant extracts comprising nucleic acid-containing particles from garlic, ginkgo, tomato, orchid, guava, ginseng, ginger, and tobacco; anticholesterol agent |
| 06/11/2009 | US20090148431 Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cells |
| 06/11/2009 | US20090148428 treatment and search for diagnostic marker of hepatocellular carcinoma (HCC), glycogen storage disease, liver dysplasia, fatty liver and other liver disease |
| 06/11/2009 | US20090148426 Composition for life extension and method of extending the life |
| 06/11/2009 | US20090148414 Novel Composition to Improve Gut Health and Animal Performance and Methods of Making the Same |
| 06/11/2009 | US20090148411 Viral vector-based gene therapy methods and compositions |
| 06/11/2009 | US20090148397 Compositions and Methods of Treatment With Proanthocyanidin Polymer Antidiarrheal Compositions |
| 06/11/2009 | US20090148396 Biocompatible biodegradable fumagillin analog conjugates |
| 06/11/2009 | US20090148395 Biomedical foam articles |
| 06/11/2009 | US20090148394 Treatment of chronic ulcerous skin lesions |
| 06/11/2009 | US20090148391 Synergistic active preparations comprising diphenylmethane derivatives and further skin and/or hair lightening and/or senile keratosis reducing compounds |
| 06/11/2009 | US20090148390 Jucara and acai fruit-based dietary supplements |
| 06/11/2009 | US20090148388 Isoindoline Compounds and Methods of Making and Using the Same |
| 06/11/2009 | US20090148384 Functionalized, solid polymer nanoparticles comprising epothilones |
| 06/11/2009 | EP1613724A2 Cell lines and host nucleic acid sequences related to infectious disease |
| 06/11/2009 | CA2744908A1 Compounds and therapeutic use thereof |
| 06/11/2009 | CA2743701A1 Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure |
| 06/11/2009 | CA2715527A1 New compounds iv |
| 06/11/2009 | CA2708223A1 Oral compositions of abt-263 for treating cancer |
| 06/11/2009 | CA2708157A1 Treatment of cancer with combinations of topoisomerase inhibitors and parp inhibitors |
| 06/11/2009 | CA2708050A1 Method for expanding hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | CA2708047A1 Process for making macrocyclic oximyl hepatitis c protease inhibitors |
| 06/11/2009 | CA2708044A1 Combination therapies using melengestrol acetate and zilpaterol or its salts |
| 06/11/2009 | CA2708042A1 Quinoxalinyl derivatives |
| 06/11/2009 | CA2708023A1 Biodegradable single-phase cohesive hydrogel |
| 06/11/2009 | CA2708022A1 Tricyclic triazolic compounds |
| 06/11/2009 | CA2707989A1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
| 06/11/2009 | CA2707823A1 A stable docusate pharmaceutical composition |
| 06/11/2009 | CA2707822A1 New compounds iii |
| 06/11/2009 | CA2707821A1 Isoxazolo-pyridazine derivatives |
| 06/11/2009 | CA2707722A1 Gamma secretase modulators |
| 06/11/2009 | CA2707718A1 Abcg2 inhibitor |
| 06/11/2009 | CA2707712A1 Gamma secretase modulators |
| 06/11/2009 | CA2707671A1 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | CA2707669A1 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | CA2707667A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 06/11/2009 | CA2707666A1 Systems and methods for delivery of materials |
| 06/11/2009 | CA2707663A1 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
| 06/11/2009 | CA2707653A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2009 | CA2707651A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 06/11/2009 | CA2707648A1 Isoxazolo-pyridine derivatives |
| 06/11/2009 | CA2707585A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/11/2009 | CA2707565A1 Renin inhibitors |
| 06/11/2009 | CA2707555A1 Piperazines as anti-obesity agents |
| 06/11/2009 | CA2707554A1 Use of 3-(indolyl)-or 3-(azaindolyl)-4-arylmaleimide derivatives in leukemia management |
| 06/11/2009 | CA2707488A1 Triazolo[4,5-d]pyrimidine compounds for treatment of abdominal aortic aneurysms |
| 06/11/2009 | CA2707484A1 Improved formulations and methods for lyophilization and lyophilates provided thereby |